Immunovaccine Inc. (T.IMV) hit a new 52-week high of 96 cents Thursday. Immunovaccine has entered into a non-exclusive clinical trial collaboration with Incyte Corporation to evaluate the combination of Immunovaccine's novel T cell activating immunotherapy, DPX-Survivac, with Incyte's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360).
Immunovaccine and Incyte will co-fund and conduct a multicenter, open-label Phase 1B study to evaluate the safety, tolerability and efficacy of the novel combination in platinum-sensitive ovarian cancer patients who are at high risk of recurrence.
Alimentation Couche-Tard Inc. (T.ATD.B) hit a new 52-week high of $54.30 Thursday. No news announcements today
Gildan Activewear Inc. (T.GIL) hit a new 52-week high of $42.02 Thursday. No news announcements today
Uni-Select Inc. (T.UNS) hit a new 52-week high of $48.04 Thursday. No news announcements today
Dollarama Inc. (T.DOL) hit a new 52-week high of $76.70 Thursday. No news announcements today
AirBoss of America Corp. (T.BOS) hit a new 52-week high of $22.15 Thursday. No news announcements today
Currency Exchange International, Corp. (T.CXI) hit a new 52-week high of $39.40 Thursday. No news announcements today
Brookfield Real Estate Services Inc. (T.BRE) hit a new 52-week high of $15.10 Thursday. No news announcements today
Clairvest Group Inc. (T.CVG) hit a new 52-week high of $29.49 Thursday. No news announcements today
Treasury Metals Inc. (T.TML) hit a new 52-week high of 59 cents Thursday. No news announcements today
